More than 38 million Americans suffer from migraine. It is the sixth most disabling neurologic disease globally, according to the World Health Organization.
Yet, migraine often is undiagnosed and left untreated. Dr. Amaal Starling, a neurologist at Mayo Clinic, says because the neurologic disease is so incapacitating, it is important to have a variety of treatment options. Dr. Starling is the lead author of a new study that looked at single pulse transcranial magnetic stimulation for the preventive treatment of migraine.
A migraine. It’s much more than a headache. And it can be debilitating.
“It’s a neurologic disease that has light sensitivity, sound sensitivity, motion sensitivity, nausea, vomiting. There are so many components,” says Dr. Starling.
There is no cure for migraine but there is a new option cleared by the U.S. Food and Drug Administration for the acute and preventive treatment of migraine.
“The device is called a single-pulse transcranial magnetic stimulation device,” says Dr. Starling.
She says the device transmits a signal to the brain, reducing brain hyperexcitability.
“Place it on the back of the head just like that [beeping]’ and then you push these two buttons,” says Dr. Starling. “And that administers a pulse.”
The first step, says Dr. Starling, is to get people with migraine to their health care provider so they can be properly diagnosed and treated.
The Latest on: Migraine
via Google News
The Latest on: Migraine
- The Real Causes and Treatments of Migraine Headaches on September 19, 2018 at 2:26 pm
Chief of Human Performance- Functionised Integrative Therapeutics (F.I.T.) Colts Neck (NJ) If you suffer from migraine headaches, you are not alone. Nearly 35 million Americans suffer from these debil... […]
- How to Find Migraine Relief Later in Life on September 19, 2018 at 2:06 pm
These headaches, which are sometimes mistaken for sinus headaches, tend to decrease later in life. But they remain fairly common: Government statistics suggest that about 7 percent of people between ... […]
- Global Migraine Drugs Market (2018-2025)-GMI Research on September 19, 2018 at 1:12 pm
Global Migraine Drugs Market by Drug Type (Abortive Drugs and Preventive Drugs), by Route of Administration (Oral, Injectables and Others), End User (Hospital Pharmacies, Retail Pharmacies and Others) ... […]
- The Monthly Migraine: The ER bill was $1,600, but the pain was worse on September 19, 2018 at 11:17 am
Being rushed to the hospital during an attack is a horrifying rite of passage for any migraine sufferer. So far, I’ve had three emergency visits to either my primary care physician or the emergency ro... […]
- Another Migraine Drug Wins Approval on September 19, 2018 at 8:12 am
The U.S. Food and Drug Administration (FDA) has approved fremanezumab (Ajovy) to prevent migraines, the second drug targeting calcitonin gene-related peptide (CGRP) to gain FDA-approval and the first ... […]
- Teva Wins Approval From FDA for Blockbuster Migraine Drug on September 18, 2018 at 10:05 pm
Prospects are looking brighter for Teva Pharmaceuticals Industries Limited (NYSE:TEVA). The company won a pair of FDA approvals in September. The big news here is the FDA approving its migraine ... […]
- Why Sex and Gender Matter in Migraine on September 18, 2018 at 9:03 am
A migraine attack is not just a headache, and not all migraine attacks are the same. The symptoms, length and frequency of migraine attacks can vary from person to person, but we know two clear ... […]
- Teva's Preventive Migraine Treatment Approved By FDA on September 17, 2018 at 3:25 pm
Teva Pharmaceutical Industries Ltd (ADR) ADR (NYSE: TEVA) — has struggled amid sagging sales of its blockbuster multiple sclerosis treatment Capaxone due to a generic launch in 2017 and its debt ... […]
- FDA Approves 2nd Migraine Prevention Drug on September 17, 2018 at 1:30 pm
Sept. 17, 2018 -- The FDA has approved Ajovy, a new drug for migraine prevention in adults, the manufacturer, Teva Pharmaceuticals, has announced. The injectable drug, known as fremanezumab, a “humani... […]
via Bing News